ExodusPoint Capital Management, LP

Position in LNTH — Lantheus Holdings, Inc.

CIK 1736225 NEW YORK, NY

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,644,661

+$236,638 QoQ

Shares Held

150,033

-30.6% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#66

of 462 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (30.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc. This page	150,033	$16,644,661
2	ELAN	Elanco Animal Health Inc	446,179	$10,980,465
3	BCRX	Biocryst Pharmaceuticals Inc	744,917	$7,449,170
4	AMRX	Amneal Pharmaceuticals, Inc.	256,843	$4,445,952
5	ANIP	Ani Pharmaceuticals Inc	32,838	$2,718,329
6	KNSA	Kiniksa Pharmaceuticals International, plc	33,017	$2,111,437
7	INDV	Indivior Pharmaceuticals, Inc.	49,984	$2,050,843
8	ALKS	Alkermes plc.	31,684	$1,660,241

All Filings in LNTH

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,644,661	150,033	-30.6%	Shares	Sole	2026-08-14
2026-03-31	$16,408,023	216,322	+401.3%	Shares	Sole	2026-05-14
2024-03-31	$2,686,029	43,156	+170.6%	Shares	Sole	2024-05-14
2023-12-31	$988,962	15,951	-93.1%	Shares	Sole	2024-02-14
2023-09-30	$15,955,039	229,635	+64.3%	Shares	Sole	2023-11-13
2023-06-30	$11,728,323	139,756	+229.9%	Shares	Other	2023-08-11
2023-03-31	$3,497,489	42,363	-40.3%	Shares	Other	2023-05-11
2022-12-31	$3,615,102	70,940	+190.9%	Shares	Other	2023-02-13
2022-09-30	$1,715,067	24,386	—	Shares	Other	2022-11-10
No filing history on record for this holder in this stock.